Breast Cancer Clinical Trial Website and Recruitment Case Study

Jonathan Eilberg • October 3, 2022

Trial AMPlify was approached by SynDevRx to create a multi-language clinical trial website, supporting graphics and a patient recruitment marketing campaign to attract eligible breast cancer subjects for its new, experimental breast cancer treatment called Evexomostat.

Clinical Trial Website Design

SynDevRx is a metabo-oncology firm based out of Cambridge, MA focused on the link between cancer and metabolic hormone dysfunction. Their drug, Evexomostat (SDX-7320) is an anti-angiogenic and anti-metabolic treatment that works in the tumor mirco environment. It is designed to be used in combination with standard-of-care therapies for multiple cancer indications, starting with HR+/Her2- and triple-negative (TNBC) breast cancer.

Clinical Study Patient Recruitment Website Design

The Challenge


SynDevRX needed to launch a new, world-class looking clinical trial website that would act as the "mother ship" for recruiting new subjects across the US as quickly as possible. 


To accomplish this, the new site needed to encompass all the best practices from the messaging and visitor journey to the design, SEO, and compliance. An effective patient recruitment marketing strategy, implementation, and ongoing campaign management was also critical for their success in announcing their clinical study and recruiting new subjects quickly.

After an extensive branding workshop, SWOT analysis and reviewing the goals of the projects, the team at Trial AMPlify went to work on pulling together all the elements to make the website, SEO, patient recruitment and compliance come together.


  • The site needed to look great and load quickly across all devices (desktop, tablet and mobile)
  • The site needed to be HIPPA compliant, and be SEO-friendly to rank well in Google searches for the keywords that mattered most to the trial.
  • The web visitor journey needed to conveyed the most important elements of the study and make sense to both the layman patient as well as medical savvy healthcare visitors.
  • A custom graphic was needed to reinforce patient study eligibility.
  • An important goal was to help patients and their doctors "self-identify" on the site and make a determination as to whether the study was a good fit.
  • Visually appealing clouds were also incorporated throughout the site to make the experience a memorable one.


Clinical trial graphic design

Perhaps the most critical element needed was a graphic to convey the science quickly and effectively. Trial AMPlify designers were asked to create a patient eligibility graphic to help relay who was a good candidate for the clinical study.

Patient Trial Eligibility Graphic
Patient Recruitment Marketing Agency

What We Accomplished


The team at Trial AMPlify interviewed the client stakeholders to better understand the recruitment objectives of the clinical trial, website tone, design look and feel, and what digital assets needed to be created.


- Conducted a SWOT analysis to review and confirm audience/ personas and demographics. Developed journey maps and strategically segmented content. Trial AMPlify then created branding guidelines, helped craft homepage messaging, designed a mood board, and delivered a formal style guide.


- Designed and developed a new, impactful parallax website with sticky navigation along with supporting graphics, an easy to understand testing lab map, and an expandable FAQ section


- An integrated video of moving clouds was used in the header of the site to compliment the new AMELIA 1 study logo and give it a unique visual appeal that would long be remembered after web visitors left the site.


- Implemented all essential SEO best practices to adhere to  Google guidelines for page # 1 search results and to maximize organic search performance for targeted key phrases.


- Reviewed and analyzed media selection. Set up a Google campaign to drive web traffic to the new website quickly to help drive patient recruitment immediately while SEO took hold. Coordinated with Google Ad Support team to verify and confirm clinical trial advertising policies were followed.


- Ensured the site was ADA compliant and followed HIPAA guidelines.


- Developed the new site on a maintenance-free, fast page-loading content management system (CMS) hosted on AWS with a CDN network in place to ensure 99.9% uptime. 90% of the Top 10 global biopharma company websites are hosted on AWS.


- Set up Google Analytics and Google Search Console. Generated and submitted an XML sitemap to Google for immediate crawling.

About Trial AMPlify 

As a leading clinical trial patient recruitment advertising agency, our goal is to ensure our clients bring their science forward and succeed at helping make the world a healthier place. Our Boston-based team of experts have worked with some of the largest biotech, life science, pharma and medical schools in the world. We equally excel at designing corporate websites for VC-backed start-ups and fledgling healthcare firms to make them look like world-class companies out of the gate.

Find out what makes us different here >>

Contact us to learn more about Trial AMPlify and see if there's a fit. You'll be in good company.


Patient Recruitment Agency

Our Role as a Patient Recruitment Company

By Jonathan Eilberg • January 23, 2025
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CROs enroll eligible and diverse study subjects.
Plaque Psoriasis

Trial AMPlify Launches a Clinical Trial Website for Alumis

By Jonathan Eilberg • January 15, 2025
Trial AMPlify, a leader in clinical trial landing page design, launches a study site for Alumis to investigate a new psoriasis medication.
Clinical Trial Marketing

Clinical Trial Marketing Best Practices for 2025

By Jonathan Eilberg • December 22, 2024
Clinical trial marketing is critical for building awareness, trust and credibility when announcing and promoting studies, but most sponsors skip this step.
Advantages of a dedicated clinical trial website versus using clinicaltrials.gov

8 Advantages of Promoting a Dedicated Clinical Trial Website vs. Your CT.gov Listing

By Jonathan Eilberg • October 18, 2024
Trial AMPlify explores the reasons why you should be using a dedicated clinical trial website versus your clinicaltrials.gov as the face of your study for patient recruitment. Learn more
Family of a clinical trial patient discussing a study

Joining a Clinical Trial: A Family Decision

By Jon Eilberg • April 28, 2024
Trial AMPlify makes the case that a clinical trial is a family decision and that it may involve a spouse, sibling, or parent who is opposed to joining a study.
Woman patient refusing to join a clinical trial

Why Patients Refuse to Join a Clinical Trial and What Sponsors Can Do About It.

By Jonathan Eilberg • December 16, 2023
Trial AMPlify examines why people refuse to join clinical trials and the critical role patient recruitment firms play in increasing enrollment. Learn more
Clinical Trial Manager

Why So Many Patient Recruitment Campaigns Fail, and What Sponsors Can Do Differently to Improve Enrollment.

By Jonathan Eilberg • December 4, 2023
Trial AMPlify examines why so many clinical trial patient recruitment campaigns fail and what can be done to help increase subject enrollment. Learn More
Clinical Trial Patient Recruitment Agency Team

The Definitive Clinical Trial Patient Recruitment Glossary of Terms

November 14, 2023
Trial AMPlify presents a list of clinical trial patient recruitment terms for when a definition might escape you. Print the document for quick reference.
Patient recruitment online questionnaires do not work

The Problem with Online Questionnaires in Clinical Trial Enrollment

By Jon Eilberg • May 29, 2023
Trial AMPlify explains why forcing patients to take online surveys hinders the ability to attract subjects and can hurt the success of a study.
Patient Recruitment Website Traffic Graph

Now is Not the Time to Push Biotech Firms to the Financial Limit

By Trial AMPlify • May 5, 2023
Trial AMPlify, a leader in clinical trial patient recruitment makes a case to help biotech’s launch studies more quickly in these tough financial times.
More Posts
Share by: